These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1789277

  • 1. The impact of selected nucleosides on the cytotoxicity of Ara-C in HL60 cells.
    Mejer J.
    Adv Exp Med Biol; 1991; 309A():97-100. PubMed ID: 1789277
    [No Abstract] [Full Text] [Related]

  • 2. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J, Mortensen BT.
    Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
    [No Abstract] [Full Text] [Related]

  • 3. A microbiological assay for cyclocytidine--disposition studies in mice.
    Neil GL, Kuentzel SL, Berger AE.
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):561-72. PubMed ID: 4633769
    [No Abstract] [Full Text] [Related]

  • 4. Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells.
    Jekunen A, Vilpo JA.
    J Natl Cancer Inst; 1984 Nov; 73(5):1087-91. PubMed ID: 6593484
    [Abstract] [Full Text] [Related]

  • 5. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
    von Dippe PJ, Leung K, Roy-Burman S, Visser DW.
    J Biol Chem; 1975 May 25; 250(10):3666-71. PubMed ID: 1092677
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
    Mejer JN, Mortensen BT, Christensen IJ.
    Med Oncol Tumor Pharmacother; 1990 May 25; 7(1):25-9. PubMed ID: 2338846
    [Abstract] [Full Text] [Related]

  • 7. Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.
    Hubeek I, Peters GJ, Broekhuizen AJ, Kaspers GJ.
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct 25; 23(8-9):1513-6. PubMed ID: 15571288
    [Abstract] [Full Text] [Related]

  • 8. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S, Cadman E.
    Cancer Res; 1982 Sep 25; 42(9):3550-6. PubMed ID: 6213294
    [Abstract] [Full Text] [Related]

  • 9. Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides.
    Kelley JA, Driscoll JS, McCormack JJ, Roth JS, Marquez VE.
    J Med Chem; 1986 Nov 25; 29(11):2351-8. PubMed ID: 3783592
    [Abstract] [Full Text] [Related]

  • 10. Ara-C metabolism: implications for drug resistance and drug interactions.
    Chabner BA, Hande KR, Drake JC.
    Bull Cancer; 1979 Nov 25; 66(1):89-92. PubMed ID: 420952
    [Abstract] [Full Text] [Related]

  • 11. On the mechanism of deoxyribonucleoside toxicity in human T-lymphoblastoid cells. Reversal of growth inhibition by addition of cytidine.
    Dahbo Y, Eriksson S.
    Eur J Biochem; 1985 Aug 01; 150(3):429-34. PubMed ID: 3874778
    [Abstract] [Full Text] [Related]

  • 12. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P, Beisler JA, Abbasi MM, Wolpert-DeFilippes MK.
    Cancer Res; 1977 Jul 01; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [Abstract] [Full Text] [Related]

  • 13. Influence of tetrahydrouridine on the phosphorylation of 1-beta-D-arabinofuranosyl-cytosine (ara-C) by enzymes from solid tumors in vitro.
    Furner RL, Mellett LB, Herren TC.
    J Pharmacol Exp Ther; 1975 Jul 01; 194(1):103-10. PubMed ID: 1057009
    [Abstract] [Full Text] [Related]

  • 14. Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
    Ashman CR, Kaufman ER, Davidson RL.
    Basic Life Sci; 1985 Jul 01; 31():391-408. PubMed ID: 3888181
    [No Abstract] [Full Text] [Related]

  • 15. Potentiation of 1-beta-D-arabinofuranosylcytosine in hepatoma cells by 2'-deoxyadenosine or 2'-deoxyguanosine.
    Harkrader RJ, Boritzki TJ, Jackson RC.
    Biochem Pharmacol; 1981 May 15; 30(10):1099-104. PubMed ID: 6973342
    [No Abstract] [Full Text] [Related]

  • 16. Sensitization to X ray by 5-chloro-2'-deoxycytidine co-administered with tetrahydrouridine in several mammalian cell lines and studies of 2'-chloro derivatives.
    Perez LM, Greer S.
    Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1523-7. PubMed ID: 3759575
    [Abstract] [Full Text] [Related]

  • 17. The synergistic lethal interaction of cis-diamminedichloroplatinum and natural nucleosides is related to increased DNA cross-links.
    Drewinko B, Dipasquale MA, Yang LY, Barlogie B, Trujillo JM.
    Chem Biol Interact; 1985 Oct 15; 55(1-2):1-12. PubMed ID: 4064187
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
    Takemura H, Urasaki Y, Yoshida A, Fukushima T, Ueda T.
    Cancer Res; 2001 Jan 01; 61(1):172-7. PubMed ID: 11196156
    [Abstract] [Full Text] [Related]

  • 19. Prevention of S-D-lactoylglutathione-induced inhibition of human leukaemia 60 cell growth by uridine.
    Edwards LG, Thornalley PJ.
    Leuk Res; 1994 Sep 01; 18(9):717-22. PubMed ID: 7934147
    [Abstract] [Full Text] [Related]

  • 20. Enhanced serum concentrations of Ara-C using suppositories containing tetrahydrouridine as a deamination inhibitor of Ara-C.
    Liversidge GG, Nishihata T, Engle KK, Higuchi T.
    J Pharm Pharmacol; 1986 Mar 01; 38(3):223-4. PubMed ID: 2871161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.